These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15017266

  • 21. Receptors for Escherichia coli adhesins in the genitourinary tract in a non-human primate.
    Ishikawa K, Sundelin B, Möllby R, Normark S, Winberg J.
    Scand J Urol Nephrol; 2004; 38(1):3-14. PubMed ID: 15204420
    [Abstract] [Full Text] [Related]

  • 22. Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney.
    Rice JC, Peng T, Spence JS, Wang HQ, Goldblum RM, Corthésy B, Nowicki BJ.
    J Am Soc Nephrol; 2005 Dec; 16(12):3583-91. PubMed ID: 16236807
    [Abstract] [Full Text] [Related]

  • 23. Systemic and mucosal antibody responses to selected cell surface antigens of avian pathogenic Escherichia coli in experimentally infected chickens.
    Kariyawasam S, Wilkie BN, Hunter DB, Gyles CL.
    Avian Dis; 2002 Dec; 46(3):668-78. PubMed ID: 12243531
    [Abstract] [Full Text] [Related]

  • 24. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
    Brooks SJ, Lyons JM, Braude AI.
    Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
    [Abstract] [Full Text] [Related]

  • 25. Local immune response to Escherichia coli pili in experimental pyelonephritis.
    Smith JW, Wagner S, Swenson RM.
    Infect Immun; 1981 Jan; 31(1):17-20. PubMed ID: 6111536
    [Abstract] [Full Text] [Related]

  • 26. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
    Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ.
    Science; 1997 Apr 25; 276(5312):607-11. PubMed ID: 9110982
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO, Luiz WB, Sbrogio-Almeida ME, Nishimura LS, Guth BE, Ferreira LC.
    Infect Immun; 2004 Nov 25; 72(11):6480-91. PubMed ID: 15501779
    [Abstract] [Full Text] [Related]

  • 30. [Effect of immunization with Escherichia coli J5 on the course of experimental pyelonephritis in rats].
    Straube E, Naumann G, Broschewitz U.
    Z Urol Nephrol; 1988 Apr 25; 81(4):247-55. PubMed ID: 3041706
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Serological response to P-fimbriae of Escherichia coli in patients with urinary tract infections.
    Agata N, Ohta M, Miyazawa H, Mori M, Kido N, Kato N.
    Eur J Clin Microbiol Infect Dis; 1989 Feb 25; 8(2):156-9. PubMed ID: 2566483
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunization with the binding domain of FimH, the adhesin of type 1 fimbriae, does not protect chickens against avian pathogenic Escherichia coli.
    Vandemaele F, Ververken C, Bleyen N, Geys J, D'Hulst C, Addwebi T, van Empel P, Goddeeris BM.
    Avian Pathol; 2005 Jun 25; 34(3):264-72. PubMed ID: 16191712
    [Abstract] [Full Text] [Related]

  • 37. A new candidate vaccine for Escherichia coli pyelonephritis.
    Stapleton A.
    J Urol; 2004 Apr 25; 171(4):1686-7. PubMed ID: 15017267
    [No Abstract] [Full Text] [Related]

  • 38. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LC.
    Vaccine; 2005 Mar 31; 23(19):2430-8. PubMed ID: 15752829
    [Abstract] [Full Text] [Related]

  • 39. Comparative evaluation of a vaccine candidate expressing enterotoxigenic Escherichia coli (ETEC) adhesins for colibacillosis with a commercial vaccine using a pig model.
    Hur J, Lee JH.
    Vaccine; 2012 Jun 06; 30(26):3829-33. PubMed ID: 22507658
    [Abstract] [Full Text] [Related]

  • 40. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK, Beavis JC, Stephens JC, Greenwood J, Gewert C, Thomas N, Deary A, Casula G, Daley A, Kelly P, Randall R, Darsley MJ.
    Infect Immun; 2006 Feb 06; 74(2):1062-71. PubMed ID: 16428753
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.